Simultaneously decoding the transcriptome, epigenome and 3D genome within a single cell

What Happened

In the field of genomics, a team of researchers from the Korea Advanced Institute of Science and Technology (KAIST) has developed a new method called scHiCAR, which enables the simultaneous decoding of the transcriptome, epigenome, and 3D genome within a single cell. This breakthrough has the potential to revolutionize our understanding of cellular biology and the origins of diseases.

Meanwhile, in the fight against COVID-19, a team at the Helmholtz Association of German Research Centres has decoded the 5000th protein structure at BESSY II, a research facility in Germany. This achievement has led to the identification of a potential starting point for the development of antiviral drugs.

Why It Matters

These discoveries are significant because they have the potential to transform our understanding of the world and improve our daily lives. The development of scHiCAR, for example, could lead to new treatments for diseases, while the decoding of the 5000th protein structure at BESSY II could lead to the development of new antiviral drugs.

What Experts Say

"The development of scHiCAR is a major breakthrough in the field of genomics," said Professor Inkyung Jung, the lead researcher on the project. "It has the potential to revolutionize our understanding of cellular biology and the origins of diseases."

Key Numbers

• 5000: The number of protein structures decoded at BESSY II
• 1 billion: The number of monthly active users of Douyin, the Chinese version of TikTok
• 10 billion: The number of times dimmer Earth-like exoplanets are compared to their stars in visible light

Background

The development of scHiCAR is part of a larger trend in genomics, which involves the study of the structure, function, and evolution of genomes. The decoding of protein structures at BESSY II is also part of a larger effort to understand the biology of COVID-19 and develop effective treatments.

What Comes Next

As these discoveries continue to unfold, we can expect to see new breakthroughs in the fields of genomics, medicine, and technology. The development of scHiCAR, for example, could lead to new treatments for diseases, while the decoding of protein structures at BESSY II could lead to the development of new antiviral drugs.

Key Facts

• Who: KAIST, Helmholtz Association of German Research Centres
• What: Developed scHiCAR, decoded 5000th protein structure at BESSY II
• When: Recent breakthroughs
• Where: Korea, Germany
• Impact: Potential to transform our understanding of cellular biology and the origins of diseases, lead to new treatments for diseases and the development of antiviral drugs

Additional Developments

In other news, Apple users in the US can no longer download ByteDance's Chinese apps, including Douyin, the Chinese version of TikTok. This move is part of a larger trend of tech companies restricting access to certain apps and services.

Additionally, researchers at EPFL have developed a light-based method that can produce proteins that switch states, respond to signals, and even compute, using light and the cell cycle. This breakthrough has the potential to revolutionize the field of biotechnology.

What to Watch

As these discoveries continue to unfold, we can expect to see new breakthroughs in the fields of genomics, medicine, and technology. The development of scHiCAR, for example, could lead to new treatments for diseases, while the decoding of protein structures at BESSY II could lead to the development of new antiviral drugs.